Just read the report. Impressive clinical trials results.
Key Highlights:
• Travelan® shigellosis challenge studies in non-human primates successfully completed
• Travelan® prevented clinical shigellosis (bacillary dysentery) in 75% of Travelan® treatedanimals compared to placebo and demonstrated a significant clinical benefit
• Prophylactic administration of Travelan® may provide an effective prevention alternative toantibiotics for gastrointestinal infections in humans
• Three new Shigella specific anti-microbial therapeutics under preclinical evaluation
• A preventative treatment that protects against enteric diseases, specifically Shigella, is a highpriority objective for the US Army
Just read the report. Impressive clinical trials results. Key...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
